The announcement comes just two weeks after Merck pulled its painkiller , Vioxx , which is in the same class of drugs as Bextra , from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer .Vioxx , Celebrex and Bextra are the only three drugs in a class known as Cox-2 inhibitors .